1-232986152-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_014801.4(PCNX2):c.6180A>T(p.Ser2060=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00167 in 1,570,334 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0078 ( 17 hom., cov: 33)
Exomes 𝑓: 0.0010 ( 22 hom. )
Consequence
PCNX2
NM_014801.4 synonymous
NM_014801.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.18
Genes affected
PCNX2 (HGNC:8736): (pecanex 2) This gene contains coding mononucleotide repeats that are associated with tumors of high mcrosatellite instability (MSI-H). Defects in this gene are involved in the tumorigenesis of MSI-H colorectal carcinomas. [provided by RefSeq, Jun 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 1-232986152-T-A is Benign according to our data. Variant chr1-232986152-T-A is described in ClinVar as [Benign]. Clinvar id is 780328.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.18 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00783 (1193/152322) while in subpopulation AFR AF= 0.0262 (1090/41572). AF 95% confidence interval is 0.0249. There are 17 homozygotes in gnomad4. There are 583 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 17 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCNX2 | NM_014801.4 | c.6180A>T | p.Ser2060= | synonymous_variant | 33/34 | ENST00000258229.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCNX2 | ENST00000258229.14 | c.6180A>T | p.Ser2060= | synonymous_variant | 33/34 | 5 | NM_014801.4 | A2 | |
PCNX2 | ENST00000344698.6 | c.2136A>T | p.Ser712= | synonymous_variant | 10/10 | 2 | P4 | ||
PCNX2 | ENST00000462233.5 | c.*1519A>T | 3_prime_UTR_variant, NMD_transcript_variant | 19/20 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00779 AC: 1186AN: 152204Hom.: 17 Cov.: 33
GnomAD3 genomes
AF:
AC:
1186
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00219 AC: 402AN: 183656Hom.: 7 AF XY: 0.00161 AC XY: 159AN XY: 98468
GnomAD3 exomes
AF:
AC:
402
AN:
183656
Hom.:
AF XY:
AC XY:
159
AN XY:
98468
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00100 AC: 1423AN: 1418012Hom.: 22 Cov.: 32 AF XY: 0.000870 AC XY: 610AN XY: 701234
GnomAD4 exome
AF:
AC:
1423
AN:
1418012
Hom.:
Cov.:
32
AF XY:
AC XY:
610
AN XY:
701234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00783 AC: 1193AN: 152322Hom.: 17 Cov.: 33 AF XY: 0.00783 AC XY: 583AN XY: 74494
GnomAD4 genome
AF:
AC:
1193
AN:
152322
Hom.:
Cov.:
33
AF XY:
AC XY:
583
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at